Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eli Lilly and Company
AddedMar 19, 2024
UpdatedJul 11, 2026
Eli Lilly and Company

Eli Lilly and Company

Public

Global pharmaceutical innovator for humans and animals. Pioneering neuroscience, endocrine, oncology, and animal health solutions.

Founded
1876
Overview
Compare
Employees
Website

Founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical innovator dedicated to discovering, developing, and marketing human and animal health solutions. The company's core mission is to make life better for people around the world through innovative medicines. Eli Lilly offers a wide range of products, including treatments for diabetes such as Humalog and Trulicity, oncology medications like Alimta, and various other pharmaceuticals targeting neuroscience and endocrine disorders.

Notable figures associated with Eli Lilly include David A. Ricks, who serves as Chair, President, and CEO, and Anat Ashkenazi, the CFO. The company is publicly traded on the NYSE under the ticker LLY and is a component of both the S&P 100 and S&P 500 indices. With a revenue of $34.12 billion in 2023, Eli Lilly has made significant strides in the pharmaceutical industry, impacting millions of lives globally through its groundbreaking medical solutions.

Eli Lilly and Company - Products & Services

  • Ebglyss logo

    Ebglyss

    A selective IL-13 inhibitor approved for atopic dermatitis in patients aged six and older.

    Competing Products

    Triveni Bio logo
    Triveni Bio logo

Eli Lilly and Company - Similar Companies

Triveni Bio logo

Triveni Bio

triveni.bio

Eli Lilly and Company - Quick Facts

Who are Eli Lilly and Company's competitors?

Companies similar to Eli Lilly and Company include Triveni Bio.

When was Eli Lilly and Company founded?

Eli Lilly and Company was founded in 1876.

How many employees does Eli Lilly and Company have?

Eli Lilly and Company has 39,000 employees as of Feb 6, 2024.

Eli Lilly and Company - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Unique IDs
  • secCik: 0000059478
  • ticker: LLY
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 38 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 522130Credit Unions
  • 420000Wholesale Trade
  • 520000Finance and Insurance
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 522000Credit Intermediation and Related Activities
  • 561000Administrative and Support Services
  • 623000Nursing and Residential Care Facilities
  • 522100Depository Credit Intermediation
  • 561400Business Support Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 561490Other Business Support Services
  • 325412Pharmaceutical Preparation Manufacturing
  • 561499All Other Business Support Services
SIC
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 6060Credit Unions
  • 6061Credit Unions, Federally Chartered
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7380Miscellaneous Business Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7389Business Services, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods
  • 6419Other monetary intermediation